Skip to main content
OpenTrials

Clinical trial condition

Estrogen Receptor Status

Explore clinical trials studying Estrogen Receptor Status. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Estrogen Receptor Status trial results

Completed

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

NCT02860000

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Status, +12 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions